Explain this page
Arphra AIPlain-English read on Alamar Biosciences, Inc.’s valuationBusiness description
· company · SEC profileAlamar Biosciences, Inc.
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
Founded
—
IPO
Apr 17, 2026
Employees
222
HQ
Fremont, CA
CEO
Justin J. McAnear
CFO
—
Exchange
NASDAQ
Fiscal year
—
Identifiers
· company_identifiersCIK0002104204
CUSIP010911105
ISINUS0109111056
FIGIALMR US
LEI—